EUVIMEDEUVIMED entdecken
Crossref

Clinical impact of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastases

Kosuke Kanemitsu, Hiromitsu Hayashi, Yoshiyuki Tagayasu, Takumi Tanizaki, Yuki Adachi, Takashi Ofuchi, Takuya Tajiri, Yuki Kitano, Hirohisa Okabe, Masaaki Iwatsuki

Surgery Today · 2026-10 · 56 (10) · 2447-2455

DOI: 10.1007/s00595-026-03377-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, online erschienen am 01.07.2026. Verfasst von Kosuke Kanemitsu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-85…. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms, Proto-Oncogene Proteins p21(ras), Hepatectomy. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSES: The Kirsten rat sarcoma viral oncogene homolog (KRAS) is defined as frequently mutated oncogenes in colorectal cancer. We aimed to clarify the clinical impact of KRAS mutation status on recurrence patterns, the surgical management of recurrent lesions, and prognostic outcomes after curative hepatectomy for colorectal liver metastases (CRLM). METHODS: The subjects of this retrospective study were 190 patients who underwent curative (macroscopic R0 resection) hepatectomy for CRLM and had wild-type (62.1%) or mutant (37.9%) KRAS status. RESULTS: KRAS mutations were associated with significantly worse overall survival (OS) and recurrence-free survival (RFS), as well as more aggressive recurrence patterns. Multivariate analysis identified KRAS mutation as an independent predictor of poor OS and RFS, whereas CEA ≥ 5 ng/mL was independently associated with OS but not RFS. Notably, patients from the mutant KRAS and wild-type KRAS groups who underwent local therapy (as repeat resection or ablation) for local recurrence had comparable OS. Conversely, among the patients who did not receive local therapy, those from the mutant KRAS group had significantly worse OS than those from the wild-type KRAS group. CONCLUSIONS: KRAS mutations are associated with aggressive recurrence patterns and a poor prognosis for patients with CRLM. However, survival following local therapy for recurrence appeared less pronounced regardless of KRAS status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsColorectal NeoplasmsProto-Oncogene Proteins p21(ras)HepatectomyMutationNeoplasm Recurrence, LocalHumansRetrospective StudiesFemaleMalePrognosisTreatment OutcomeMiddle AgedAgedSurvival Rate

Stichwörter der Autor:innen

RAS mutations, KRAS12C, KRAS12DColorectal cancerLiver metastases

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-8556, Japan.
  • Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Kumamoto Chuo-ku, Kumamoto, 860-8556, Japan. hhayasi@kumamoto-u.ac.jp.

Zitieren

APA

Kanemitsu, K., Hayashi, H., Tagayasu, Y., Tanizaki, T., Adachi, Y., Ofuchi, T., Tajiri, T., Kitano, Y., Okabe, H., & Iwatsuki, M. (2026). Clinical impact of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastases. Surgery Today, 56(10), 2447-2455. https://doi.org/10.1007/s00595-026-03377-y

Vancouver

Kanemitsu K, Hayashi H, Tagayasu Y, Tanizaki T, Adachi Y, Ofuchi T, et al. Clinical impact of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastases. Surgery Today. 2026;56(10):2447-2455. doi:10.1007/s00595-026-03377-y

BibTeX
@article{Kanemitsu2026,
  author = {Kanemitsu, Kosuke and Hayashi, Hiromitsu and Tagayasu, Yoshiyuki and Tanizaki, Takumi and Adachi, Yuki and Ofuchi, Takashi and Tajiri, Takuya and Kitano, Yuki and Okabe, Hirohisa and Iwatsuki, Masaaki},
  title = {Clinical impact of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastases},
  journal = {Surgery Today},
  year = {2026},
  volume = {56},
  number = {10},
  pages = {2447--2455},
  doi = {10.1007/s00595-026-03377-y}
}
Kostenlos starten →